| Value | ₹0.26 Cr |
|---|
NSE filing, NSE: PARADEEP. Summary written from the filing by ALFA Finder's alert engine.
Paradeep Phosphates Ltd: key numbers
- Share price
- ₹142.32
- Market cap
- ₹14,780 Cr
- Revenue (annual)
- ₹21,826 Cr
- Net profit (annual)
- ₹996.4 Cr
- P/E (TTM)
- 17.4×Sector 11.1×
- Promoter holding
- 57.85%-0.01% QoQ
- FII holding
- 4.79%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Paradeep Phosphates Ltd
All →Paradeep Phosphates Management Change
Paradeep Phosphates' independent director Satyananda Mishra ceased office on November 3, 2026, completing his second term. The change took effect at close of business.
Paradeep Phosphates Earnings Call Transcript: Key Takeaways
PPL managed a 19% H1 revenue jump despite poor monsoon and volatile sulfur prices.
Paradeep Phosphates Investor Presentation: Key Takeaways
Q2 FY27 revenue Rs 7,364 Cr (+7.2% Y-o-Y), EBITDA Rs 431 Cr (5.8% margin, down 38%), PAT Rs 122 Cr (down 64%). H1 revenue Rs 13,488 Cr (+18.6%), PAT Rs 516 Cr. Margins squeezed; no quantitative guidance.
Paradeep Phosphates Results Update
Paradeep Phosphates reported Q2 FY27 revenue of ₹7,364 crore and PAT of ₹122 crore. H1 FY27 turnover reached ₹13,488 crore on 2 million tons sold.
Paradeep Phosphates Q2 FY27 Results: Net Profit ₹121 Cr, Down 64.6% YoY
Paradeep Phosphates Ltd reported revenue from operations of ₹7,364 Cr (+7.2% YoY) and net profit of ₹121 Cr (-64.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹121 Cr · -64.6% YoY
Paradeep Phosphates Board Meeting Date
Paradeep Phosphates informed exchanges that its Board is scheduled to meet on 29 Oct 2026 to consider unaudited Q1 and H1 results. The trading window remains closed till 31 Oct 2026.
Other business update announcements
All →Italian Edibles Business Update
Italian Edibles revised its project timeline again, pushing commercial production from January 2027 to April 2027. Construction delays stem from steel prices, supply chain disruption, weather and labour shortages.
- Execution
- Commercial production revised to April 2027 from January 2027
Bajaj Finserv Business Update
Bajaj Finserv disclosed October 2026 monthly premium and new business data for its unlisted insurance subsidiaries. The figures are provisional.
Bajaj Finance Business Update
Bajaj Finance submitted its Half Yearly Report for FY2026-27 covering the six months to 30 September 2026. The report shows 28% consolidated PAT growth to ₹12,447 crore and a planned ₹17,500 crore capital raise.
Cohance Lifesciences Business Update
Cohance Lifesciences disclosed that USFDA issued the Establishment Inspection Report for its Pashamylaram facility, classifying the inspection as Voluntary Action Indicated. The inspection is now concluded.
Religare Enterprises Business Update
Religare Finvest, a material subsidiary, resumed lending after RBI lifted its Corrective Action Plan. It disbursed its first Loan Against Property on 6 November 2026.
Purple Wave Infocom Business Update
Purple Wave signed a 5-year data integration agreement with BPCL for its Hygiair devices. The Rs 10 crore figure is indicative, not firm order value.
- Execution
- 5 years